NCT01027091

Brief Summary

Hypocalcemia is the complication, after total thyroidectomy, that usually determines the length of hospital stay.Serum calcium levels is a quick and cost-effective practice to recognise hypocalcemia in the postoperative follow up. OBJECTIVE: The objective of this perspective study is to determine if consecutive postoperative serum calcium levels early after total thyroidectomy can be used to identify patients who are unlikely to develop significant hypocalcemia and can be safely discharged within 24 to 48 hours postoperative.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2008

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2008

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

December 4, 2009

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 7, 2009

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2010

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2011

Completed
Last Updated

December 7, 2009

Status Verified

November 1, 2009

Enrollment Period

1.6 years

First QC Date

December 4, 2009

Last Update Submit

December 4, 2009

Conditions

Keywords

hypocalcemiatotal thyroidectomy

Outcome Measures

Primary Outcomes (1)

  • Correlation of the variability of the levels of free serum calcium (Ca + +), between two measurements on 6 and 12 hours postoperatively, the incidence of hypocalcaemia in patients undergoing total thyroidectomy for any reason.

    6hr, 12hr, 24hr, 48hr postopreratively

Secondary Outcomes (4)

  • The correlation between development of hypocalcaemia in patients after total thyroidectomy with the following factors: · Gender, · Age,

  • The correlation between development of hypocalcaemia and the Intraoperative recognition of parathyroid glands and possible autotransplantation of parathyroid glands,

  • The correlation between development of hypocalcaemia in patients after total thyroidectomy with the Underlying thyroid pathology based on the histological-pathological report:

  • The correlation between development of hypocalcaemia in patients after total thyroidectomy with the following factors: Use of Ligasure use of Ultracision, Use of hemostatic,Volume of blood loss, Volume and weight of specimen

Study Arms (2)

patients with positive slope

patients with positive slope in the levels of free serum calcium levels between 6th and 12th postoperative hour

patients with negative or no slope

patients with negative or no slope in the levels of free serum calcium levels between 6th and 12th postoperative hour.

Eligibility Criteria

Age16 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients with any thyroid pathology undergoing total thyroidectomy regardless of gender, age and medication

You may qualify if:

  • patients with any thyroid pathology undergoing total thyroidectomy regardless of gender, age and medication

You may not qualify if:

  • patients treated with substitutes calcium and vitamin D.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

G.Hatzikosta General Hospital

Ioannina, Ioannina, 45221, Greece

RECRUITING

MeSH Terms

Conditions

Hypocalcemia

Condition Hierarchy (Ancestors)

Calcium Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesWater-Electrolyte Imbalance

Study Officials

  • Evangelos K Tsimoyiannis, DR, MD, FACS, FABI,

    G. Hatzikosta General Hospital

    STUDY DIRECTOR

Central Study Contacts

George A. Economou, M.D

CONTACT

Evangelos K Tsimoyiannis, M.D, DR., FACS, FABI

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

December 4, 2009

First Posted

December 7, 2009

Study Start

November 1, 2008

Primary Completion

June 1, 2010

Study Completion

January 1, 2011

Last Updated

December 7, 2009

Record last verified: 2009-11

Locations